Fremanezumab

Generic Name: Fremanezumab-vfrm

Brand Names: Ajovy

Fremanezumab is a CGRP inhibitor injection for migraine prevention, available as monthly or quarterly dosing.

NeurologicMigraine Prevention

What It's Used For

Fremanezumab is prescribed for:

Migraine prevention
Episodic and chronic migraine
Neurologic headache management

Offers flexible monthly or quarterly dosing options.

Side Effects

Common side effects:

Injection site reactions
Pain at injection site

Generally very well tolerated with minimal systemic side effects.

Additional Information

What is Fremanezumab?

Fremanezumab is a CGRP-targeting monoclonal antibody for migraine prevention.

Dosing Flexibility

Can be administered as:

225 mg monthly
675 mg quarterly (three 225 mg injections)

Advantages

Quarterly dosing option
Works quickly (some benefit within first week)
No liver metabolism concerns

Learn more at MedlinePlus.

Related Health Conditions

This medication is commonly used to treat or manage the following conditions:

Migraine

Migraine is a debilitating neurological condition causing recurrent headaches with throbbing pain, nausea, and light/sound sensitivity, likely stemming from complex brain, nerve, and blood vessel interactions.

Learn More

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.

Loading questions...

Ask Dr. Zimmer

Have questions about Fremanezumab? Get expert answers from Dr. Zimmer.

Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.

Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.

Menu